The article reports on the increasing competition in the market of blood disorder treatment in the U.S. Among the companies that are involved in the competition are Amgen, Pfizer, Genentech and other manufactures of the thrombopoietin (TPO) mimetic drugs. In addition, blood diseases can be cured with platelet growth factors, by improving the production of the protein based TPO in the blood.